CTLA4 anticorps (N-Term)
Aperçu rapide pour CTLA4 anticorps (N-Term) (ABIN2138472)
Antigène
Voir toutes CTLA4 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- CTLA4 antibody was purified through a protein A column, followed by peptide affinity purification
-
Immunogène
- CTLA4 antibody (N terminal) was raised in Rabbit using a KLH conjugated synthetic peptide between 57-86 amino acids from the N-terminal region of human IDDM12 as the immunogen
-
Isotype
- IgG
-
-
-
-
Indications d'application
- ELISA: 1:1000, IHC: 1:1:50-100, WB: 1:100-500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid In PBS with 0.09 % (W/V) sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
-
Stock
- -20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4))
-
Autre désignation
- CTLA4
-
Pathways
- Cancer Immune Checkpoints
Antigène
-